Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

LivaNova PLC

LIVN ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Mid Cap Analyst: BUY

Last Close

$79.41

▲ +1.47%

Market Cap $4.37B · Vol 215.56K

Key Metrics

P/E Ratio

47.15

FWD: 17.32

Market Cap

$4.37B

Mid Cap

Div Yield

N/A

Semi-annual dividend

EPS Growth

+12.01%

YoY

RSI (14)

53.73

Momentum

Beta

0.87

vs Market

52W High

$85.76

7.40% below

52W Low

$48.90

62.39% above

Volume

215.56K

Avg 211.10K

P/B

2.80

Price-to-book

ROE

17.03%

Return on equity

Free Float

99.58%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, LivaNova PLC (LIVN) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does LIVN pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-0.56%

+1.56%

+7.56%

+12.97%

YTD

+29.06%

+40.92%

+42.49%

-4.33%

Financials & Valuation

TTM · Annual

Total Revenue	$1.39B
Net Income	$-242,420,000.00
Revenue Growth (YoY)	+10.80%
Gross Margin	67.71%
Operating Margin	-11.64%
Net Profit Margin	-17.47%
ROE	17.03%
ROA · ROIC	-8.64% · N/A

P/E Ratio	47.15
Forward P/E (FY1)	17.32
PEG Ratio	N/A
P/S	2.42
P/B	2.80
P/FCF	19.37
EPS Growth	+12.01%
Outstanding Shares	55.09M

Technical Indicators

50-Day SMA	$80.46
200-Day SMA	$68.68
RSI (14)	53.73
Beta	0.87
52-Week High	$85.76
52-Week Low	$48.90

Volume Today	215.56K
Avg Daily Volume (30D)	211.10K
Relative Volume	1.02x
Volatility (10D)	27.74
Volatility (30D)	38.63
Free Float	99.58%

Analyst Consensus

BUY

Current Price $79.41

Mean Target $88.13

52W Low$48.90 52W High$85.76

Current

Target

$48.90 $85.76

Current Analyst target

+10.98% upside potential · 11 analysts

Identifiers

ExchangeNasdaq

FIGIBBG009LGHG25

ISINGB00BYMT0J19

CountryUnited Kingdom

Sub-IndustryMedical Equipment, Supplies & Distribution (NEC)

Earnings DateNov 3, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ABT Abbott Laboratories -0.46% MDT Medtronic PLC -1.89% COR Cencora Inc +1.33% 7741.T Hoya Corp +0.40% BDX Becton Dickinson and Co -0.50%

Company Profile

LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.